About Sartorius Aktiengesellschaft (SRT3)
Sartorius Aktiengesellschaft is a Medical Instruments & Supplies company operating in the Healthcare sector. The company is headquartered in Göttingen, Germany. SRT3 has been publicly traded since 1999, giving it 27+ years of trading history.
Sartorius Aktiengesellschaft (SRT3) has been publicly traded since 1999, making it a 27-year-old public company. It operates in the Medical Instruments & Supplies industry within the Healthcare sector. The company is headquartered in Göttingen, Germany and employs approximately 13,299 people. With a market capitalization of €14 billion, SRT3 is a large established company.
SRT3 trades on the German stock exchanges (XETRA/Frankfurt) and is classified as a large-cap-cap stock with a market capitalization of approximately €14 billion. The company employs approximately 13,299 people worldwide.
Key Statistics
- Current Price
- €209.70
- Market Cap
- €14.48B
- 52-Week High
- €267.70
- 52-Week Low
- €166.05
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
SRT3 Investment Performance
SRT3 has declined 15.2% year-to-date in 2026. Over the past 5 years, a €1,000 investment in SRT3 would have grown to €499, representing a -50.1% total return. Since its IPO in 1999, a €1,000 investment would now be worth €209,891.
€1,000 Invested in Sartorius Aktiengesellschaft (SRT3)
How much would €1,000 invested in SRT3 be worth today?
What would €1,000 invested in SRT3 1 year ago be worth today?
A €1,000 investment in Sartorius Aktiengesellschaft (SRT3) in 2025 would be worth €982 as of March 2026, representing a -1.8% total return.
What would €1,000 invested in SRT3 3 years ago be worth today?
A €1,000 investment in Sartorius Aktiengesellschaft (SRT3) in 2023 would be worth €545 as of March 2026, representing a -45.5% total return.
What would €1,000 invested in SRT3 5 years ago be worth today?
A €1,000 investment in Sartorius Aktiengesellschaft (SRT3) in 2021 would be worth €499 as of March 2026, representing a -50.1% total return.
What would €1,000 invested in SRT3 10 years ago be worth today?
A €1,000 investment in Sartorius Aktiengesellschaft (SRT3) in 2016 would be worth €3,883 as of March 2026, representing a +288.3% total return.
What would €1,000 invested in SRT3 at IPO be worth today?
A €1,000 investment in Sartorius Aktiengesellschaft (SRT3) at IPO would be worth €209,891 as of March 2026, representing a +20889.1% total return.
Monthly Returns Heatmap
Over the past 26+ years (323 months), Sartorius Aktiengesellschaft (SRT3) has averaged a monthly return of +2.26% with a median return of +1.94%. The stock had 188 positive months (58%) and 132 negative months (41%). The best month in SRT3's history was April 2004 with a +41.5% return, while the worst was October 2008 at -47.6%. Historically, February tends to be the strongest month (averaging +4.8%), and September the weakest (-3.5%).
SRT3's longest winning streak was 10 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 2004 with a cumulative return of +98.3%, and the worst was 2008 at -89.6%.
Annual Returns
Over 27 years of trading history, Sartorius Aktiengesellschaft (SRT3) has delivered an average annual return of +34.00% with a median return of +30.39%. The compound annual growth rate (CAGR) is +21.51%. The stock posted gains in 19 years (70%) and losses in 8 years (30%).
SRT3's best year was 2015 with a +139.57% gain, while the worst was 2008 at -68.92%. The longest streak of consecutive positive years was 13, and the longest losing streak was 3 years. SRT3 achieved double-digit gains (10%+) in 19 years. It suffered double-digit losses in 7 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -15.17% | €247.20 | €209.70 |
| 2025 | +13.88% | €217.07 | €247.20 |
| 2024 | -34.50% | €331.42 | €217.07 |
| 2023 | -9.48% | €366.12 | €331.42 |
| 2022 | -37.74% | €588.01 | €366.12 |
| 2021 | +73.51% | €338.89 | €588.01 |
| 2020 | +80.30% | €187.96 | €338.89 |
| 2019 | +75.92% | €106.84 | €187.96 |
| 2018 | +37.51% | €77.70 | €106.84 |
| 2017 | +13.47% | €68.47 | €77.70 |
| 2016 | +18.06% | €58.00 | €68.47 |
| 2015 | +139.57% | €24.21 | €58.00 |
| 2014 | +18.22% | €20.48 | €24.21 |
| 2013 | +30.39% | €15.70 | €20.48 |
| 2012 | +92.65% | €8.15 | €15.70 |
| 2011 | +31.69% | €6.19 | €8.15 |
| 2010 | +76.18% | €3.51 | €6.19 |
| 2009 | +106.92% | €1.70 | €3.51 |
| 2008 | -68.92% | €5.46 | €1.70 |
| 2007 | -16.90% | €6.57 | €5.46 |
| 2006 | +63.96% | €4.01 | €6.57 |
| 2005 | +37.79% | €2.91 | €4.01 |
| 2004 | +131.51% | €1.26 | €2.91 |
| 2003 | +91.62% | €0.66 | €1.26 |
| 2002 | -45.34% | €1.20 | €0.66 |
| 2001 | -12.22% | €1.37 | €1.20 |
| 2000 | +24.99% | €1.09 | €1.37 |
SRT3 Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Sartorius Aktiengesellschaft as an investment
Valuation
SRT3 currently trades at a trailing P/E ratio of 93.6, which is considered high relative to the broader market. The forward P/E of 31.2 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 5.3. The price-to-sales ratio is 4.1.
Dividends
Sartorius Aktiengesellschaft pays a dividend to shareholders with a current yield of 0.35%. This translates to €0.74 per share annually. The payout ratio of 33% indicates sustainable dividend coverage.
Risk & Volatility
SRT3 has a beta of 1.51, indicating it is significantly more volatile than the overall market. The stock's 52-week range is €166.05 to €267.70, and it currently trades in the lower half of its 52-week range.
Analyst Ratings
Based on 19 analyst opinions, SRT3 has a consensus "buy" rating. The average price target of €265.37 suggests 26.5% upside from current levels.
Frequently Asked Questions: SRT3
What sector is SRT3 in? ▼
SRT3 operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has SRT3 performed historically? ▼
Over 27 years of trading history, SRT3 has posted gains in 19 years (70% of the time). The best year was 2015 with a +139.6% return. Past performance does not guarantee future results.
How can I invest in SRT3? ▼
You can invest in SRT3 through any brokerage account that offers access to German exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold SRT3.
Does SRT3 pay dividends? ▼
Sartorius Aktiengesellschaft pays a dividend to shareholders with a current yield of 0.35%. This translates to €0.74 per share annually. The payout ratio of 33% indicates sustainable dividend coverage.
What does Sartorius Aktiengesellschaft do? ▼
Sartorius Aktiengesellschaft is a Medical Instruments & Supplies company operating in the Healthcare sector. The company is headquartered in Göttingen, Germany.
What sector is SRT3 in? ▼
SRT3 operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry.
When did SRT3 go public? ▼
Sartorius Aktiengesellschaft went public in 1999, making it a 27-year-old public company as of 2026.
How much would €1,000 invested in SRT3 5 years ago be worth today? ▼
A €1,000 investment in SRT3 five years ago would be worth approximately €499 today, representing a -50.1% return.
How much would €1,000 invested in SRT3 10 years ago be worth today? ▼
A €1,000 investment in SRT3 ten years ago would be worth approximately €3,883 today, representing a 288.3% total return over the decade.
What is SRT3's 3-year return? ▼
Over the past 3 years, SRT3 has returned -45.5%. A €1,000 investment would have grown to €545.
How much would €1,000 invested in SRT3 at IPO be worth today? ▼
If you invested €1,000 in SRT3 at its IPO in 1999, it would be worth approximately €209,891 today, a 20,889.1% return over 27 years.
Does SRT3 pay dividends? ▼
Yes, Sartorius Aktiengesellschaft pays a dividend with a current yield of 0.35%, which is €0.74 per share annually.
What is SRT3's market cap? ▼
Sartorius Aktiengesellschaft has a market capitalization of €14 billion, classifying it as a large-cap company.
What is SRT3's P/E ratio? ▼
SRT3 has a trailing P/E ratio of 93.6 and a forward P/E of 31.2, which measures how much investors are paying per dollar of earnings.
Is SRT3 a buy, hold, or sell? ▼
Based on 19 opinions, SRT3 has a consensus "buy" rating. The average price target is €265.37.
Last updated: 3/15/2026